Chemical Structure (Bortezomib For Injection 1)
Bortezomib Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9098
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Bortezomib (NDC 0143-9098). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Bortezomib For Injection 2)
Figure 2 (Bortezomib For Injection 3)
This appears to be a medical statistic table showing the percentage of patients and number of patients at risk over time. The time is measured in months. No other information on the medical condition is provided.*
Figure 3 (Bortezomib For Injection 4)
Figure 4 (Bortezomib For Injection 5)
This appears to be a tabular data presenting information about Bortezomib and Dexamethasone, along with the number of patients remaining after a certain point in time and their corresponding p-values from log-rank test. The table shows varying values of Bortezomib and Dexamethasone at different timepoints.*
Figure 5 (Bortezomib For Injection 6)
Figure 6 (Bortezomib For Injection 7)
This is a plot representing the percentage of subjects alive over time. The hazard ratio with 85% confidence interval is also given. There are two groups of subjects, one treated with VGR-CAP and the other with R-CHOP, with the number of subjects at risk over time for each group. No additional information is available.*
Hikma Vial Label (Bortezomib For Injection 8)
Bortezomib for Injection is a cytotoxic agent used for Intravenous or Subcutaneous Use. The lyophilized vial contains 3.5 mg bortezomib and 35 mg mannitol, USP. This Single-Dose Vial should be discarded after use. The Usual Dosage can be found in the accompanying package insert. It is recommended to Store at 25°C (77°F), with excursions permitted from 15°to 30°C (59°to 86°F) (See USP Controlled Room Temperature) and protect from light. It is Manufactured in China by Jiangsu Hansoh Pharmaceutical Group Co., Ltd and Distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922. The Lot number is Bxp. 602218801.*
Hikma Carton (Bortezomib For Injection 9)
This text appears to be a product label for Bortezomib, a medication used for injection. It provides some information on the contents and typical dosage, as well as instructions for use. The label appears to have been scanned incorrectly, resulting in some garbled text and unclear characters.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
